Назорат саволлари:
1.Генерик, оригинал препарат ва нусха-препарат тушунчалари, уларнинг
фарқлари.
2.Патент ҳимояси, бозорда дори воситасини сотиш учун мутлоқ ҳуқуқ.
3.Дори воситаларининг эквивалентлик тушунчаси, турлари.
4. Биологик эквивалентлик. КНИ аниқлаш усуллари.
Фойдаланилган адабиётлар:
1.
Elina Petrova. Innovation in the Pharmaceutical Industry: The
Process
of Drug Discovery and Development. – 2014. – 81р.
2.
ЕМЕА, The rules governing medicinal products
in the European Union
investigation of bioavailability and bioequivalence, v. 3c, 2000, pp.
231−244.
3.
FDA, Electronic Orange Book.Approved Drug
Products With Therapeutic
Equivalence Evaluations, 20th Edition, 2000.
4.
FDA, Electronic Orange Book, Approved Drug Products With Therapeutic
Equivalence Evaluations, 20th Edition, 2000.
